These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29037468)

  • 1. Insights Into the Pathophysiology of Esophageal Adenocarcinoma.
    Quante M; Graham TA; Jansen M
    Gastroenterology; 2018 Jan; 154(2):406-420. PubMed ID: 29037468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Carcinogenesis of Barrett's esophagus].
    Endo T; Sugawara N; Shinomura Y
    Nihon Rinsho; 2005 Aug; 63(8):1357-61. PubMed ID: 16101221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma.
    Wang RH
    World J Gastroenterol; 2015 May; 21(17):5210-9. PubMed ID: 25954094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic High-Fat Diet Induces Early Barrett's Esophagus in Mice through Lipidome Remodeling.
    Molendijk J; Nguyen TM; Brown I; Mohamed A; Lim Y; Barclay J; Hodson MP; Hennessy TP; Krause L; Morrison M; Hill MM
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32429496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Content Imaging of Barrett's-Associated High-Grade Dysplasia Cells After siRNA Library Screening Reveals Acid-Responsive Regulators of Cellular Transitions.
    Phipps SM; Garry CE; Kamal S; Johnson JD; Gilmer J; Long A; Kelleher D; Duggan SP
    Cell Mol Gastroenterol Hepatol; 2020; 10(3):601-622. PubMed ID: 32416156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current challenges in Barrett's esophagus.
    Falk GW
    Cleve Clin J Med; 2001 May; 68(5):415-7, 422-4. PubMed ID: 11352321
    [No Abstract]   [Full Text] [Related]  

  • 7. The pathogenesis of Barrett's metaplasia and the progression to esophageal adenocarcinoma.
    Grotenhuis BA; van Lanschot JJ; Dinjens WN; Wijnhoven BP
    Recent Results Cancer Res; 2010; 182():39-63. PubMed ID: 20676870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barrett's esophagus: recent insights into pathogenesis and cellular ontogeny.
    Kapoor H; Agrawal DK; Mittal SK
    Transl Res; 2015 Jul; 166(1):28-40. PubMed ID: 25701368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch Signaling Mediates Differentiation in Barrett's Esophagus and Promotes Progression to Adenocarcinoma.
    Kunze B; Wein F; Fang HY; Anand A; Baumeister T; Strangmann J; Gerland S; Ingermann J; Münch NS; Wiethaler M; Sahm V; Hidalgo-Sastre A; Lange S; Lightdale CJ; Bokhari A; Falk GW; Friedman RA; Ginsberg GG; Iyer PG; Jin Z; Nakagawa H; Shawber CJ; Nguyen T; Raab WJ; Dalerba P; Rustgi AK; Sepulveda AR; Wang KK; Schmid RM; Wang TC; Abrams JA; Quante M
    Gastroenterology; 2020 Aug; 159(2):575-590. PubMed ID: 32325086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal Model: Reflux Models in Esophageal Adenocarcinoma.
    Masuda T; Mittal SK
    Methods Mol Biol; 2018; 1756():143-150. PubMed ID: 29600367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma.
    Wennerström EC; Risques RA; Prunkard D; Giffen C; Corley DA; Murray LJ; Whiteman DC; Wu AH; Bernstein L; Ye W; Chow WH; Vaughan TL; Liao LM
    Cancer Med; 2016 Sep; 5(9):2657-65. PubMed ID: 27384379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular mechanisms of Barrett's esophagus development.
    Barbera M; Fitzgerald RC
    Surg Oncol Clin N Am; 2009 Jul; 18(3):393-410. PubMed ID: 19500732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogenesis and epidemiology of Barrett esophagus].
    Spechler SJ
    Chirurg; 1994 Feb; 65(2):84-7. PubMed ID: 8162820
    [No Abstract]   [Full Text] [Related]  

  • 14. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma.
    Runge TM; Abrams JA; Shaheen NJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):203-31. PubMed ID: 26021191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
    Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
    Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical outline of Barrett's esophagus].
    Kuwano H; Sohda M; Kato H; Miyazaki T; Kimura H
    Nihon Rinsho; 2005 Aug; 63(8):1372-8. PubMed ID: 16101224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Present Status and Future of Barrett's Esophageal Adenocarcinoma in Japan.
    Nishi T; Makuuchi H; Ozawa S; Shimada H; Chino O
    Digestion; 2019; 99(2):185-190. PubMed ID: 30481763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Barrett's esophagus free of dysplasia.
    DeMeester SR
    Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):279-84. PubMed ID: 9263346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carditis, intestinal metaplasia and adenocarcinoma of oesophagogastric junction.
    Conio M; Filiberti R; Blanchi S; Giacosa A
    Eur J Cancer Prev; 2001 Dec; 10(6):483-7. PubMed ID: 11916346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Troublesome Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma.
    Schneider JL; Corley DA
    Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):353-364. PubMed ID: 28577761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.